Skip to content

Jeff Sutherland

Twice the Energy with Half the Stress

Emerging BioTech: Great Opportunities for Electronic Medicine

New biotech directions provide significant opportunity for electronic medicine. The article below focuses on altering genes to stop replication of AIDs virus, cancer cells, and so forth. However, the genes simply stop creation of proteins and electromagnetic fields can eliminate these same proteins.

In future years, researchers will find that genetic engineering can be accomplished more easily with electromagnetic fields. Meanwhile, electromedicine researchers can focus on identifying specific proteins causing health problems and knock them out with a frequency device.

RNAi Therapy

Thomas Tuschl

10 Emerging Technologies That Will Change Your World

MIT Technology Review, February 2004

From heart disease to hepatitis, cancer to AIDS, a host of modern ailments are triggered by our own errant genes—or by those of invading organisms. So if a simple technique could be found for turning off specific genes at will, these diseases could—in theory—be arrested or cured. Biochemist Thomas Tuschl may have found just such an off switch in humans: RNA interference (RNAi). While working at Germany’s Max Planck Institute for Biophysical Chemistry, Tuschl discovered that tiny double-stranded molecules of RNA designed to target a certain gene can, when introduced into human cells, specifically block that gene’s effects.